Oud-Turnhout, Belgium

Joannes J Willems

This inventor holds 5 USPTO granted patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 1982-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joannes J Willems. Retrieved from https://idiyas.com/inventor/joannes-j-willems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 69(Granted Patents)


Location History:

  • Turnhout, BE (1982 - 1991)
  • Oud-Turnhout, BE (1992 - 1994)

Company Filing History:


Years Active: 1982-1994

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Joannes J Willems: Innovator in Anti-Viral Research

Introduction

Joannes J Willems is a notable inventor based in Oud-Turnhout, Belgium. He has made significant contributions to the field of anti-viral research, holding a total of 5 patents. His work focuses on developing innovative solutions for treating viral diseases in warm-blooded animals.

Latest Patents

Willems' latest patents include the invention of anti-virally active pyridazinamines. These patents detail compositions containing these compounds and methods for treating viral diseases. His research aims to provide effective treatments that can enhance the health and well-being of affected animals.

Career Highlights

Joannes J Willems is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at this organization has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Raymond A Stokbroekx and Marcel G Luyckx. Their combined expertise has fostered a collaborative environment that promotes innovation and advancement in anti-viral treatments.

Conclusion

Joannes J Willems stands out as an influential inventor in the realm of anti-viral research. His contributions through patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…